Genetic markers in breast cancer – how far fave we come from BRCA1?

Breast cancer is the most common malignancy that develops in women worldwide, its incidence continues to rise and it is responsible for the highest death rates. Breast cancer can be classified as sporadic or familial – the strongest risk factor today is a family history. Germline mutations in high...

Full description

Bibliographic Details
Main Authors: Avery-Kiejda, Kelly A., Wong, Michelle W., Scott, Rodney J.
Format: Article
Language:English
Published: UKM Medical Molecular biology Institute, UMBI 2011
Online Access:http://journalarticle.ukm.my/3061/
http://journalarticle.ukm.my/3061/
http://journalarticle.ukm.my/3061/1/2011-1-3.pdf
id ukm-3061
recordtype eprints
spelling ukm-30612016-12-14T06:33:28Z http://journalarticle.ukm.my/3061/ Genetic markers in breast cancer – how far fave we come from BRCA1? Avery-Kiejda, Kelly A. Wong, Michelle W. Scott, Rodney J. Breast cancer is the most common malignancy that develops in women worldwide, its incidence continues to rise and it is responsible for the highest death rates. Breast cancer can be classified as sporadic or familial – the strongest risk factor today is a family history. Germline mutations in high-penetrance breast cancer susceptibility genes BRCA1 and BRCA2 have been strongly implicated in the genetic predisposition of approximately 20% of familial breast cancers. Although BRCA1 and BRCA2 do not account for all familial breast cancers, there are currently no other genes that have been identified which segregate with familial breast cancer as strongly. Despite large-scale attempts to identify genetic risk factors associated with breast cancer, the variants identified through genome-wide association studies (GWAS), only confer a modest increase in risk of breast cancer and at present lack clinical utility. This review will discuss the known genetic risk factors for developing breast cancer and how far the field has progressed since the identification of BRCA1. UKM Medical Molecular biology Institute, UMBI 2011 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/3061/1/2011-1-3.pdf Avery-Kiejda, Kelly A. and Wong, Michelle W. and Scott, Rodney J. (2011) Genetic markers in breast cancer – how far fave we come from BRCA1? Asia-Pacific Journal of Molecular Medicine, 1 . pp. 1-8. ISSN 2232-0326 http://www.umbi.ukm.my/umbi/index.php?option=com_content&task=view&id=388&Itemid=72
repository_type Digital Repository
institution_category Local University
institution Universiti Kebangasaan Malaysia
building UKM Institutional Repository
collection Online Access
language English
description Breast cancer is the most common malignancy that develops in women worldwide, its incidence continues to rise and it is responsible for the highest death rates. Breast cancer can be classified as sporadic or familial – the strongest risk factor today is a family history. Germline mutations in high-penetrance breast cancer susceptibility genes BRCA1 and BRCA2 have been strongly implicated in the genetic predisposition of approximately 20% of familial breast cancers. Although BRCA1 and BRCA2 do not account for all familial breast cancers, there are currently no other genes that have been identified which segregate with familial breast cancer as strongly. Despite large-scale attempts to identify genetic risk factors associated with breast cancer, the variants identified through genome-wide association studies (GWAS), only confer a modest increase in risk of breast cancer and at present lack clinical utility. This review will discuss the known genetic risk factors for developing breast cancer and how far the field has progressed since the identification of BRCA1.
format Article
author Avery-Kiejda, Kelly A.
Wong, Michelle W.
Scott, Rodney J.
spellingShingle Avery-Kiejda, Kelly A.
Wong, Michelle W.
Scott, Rodney J.
Genetic markers in breast cancer – how far fave we come from BRCA1?
author_facet Avery-Kiejda, Kelly A.
Wong, Michelle W.
Scott, Rodney J.
author_sort Avery-Kiejda, Kelly A.
title Genetic markers in breast cancer – how far fave we come from BRCA1?
title_short Genetic markers in breast cancer – how far fave we come from BRCA1?
title_full Genetic markers in breast cancer – how far fave we come from BRCA1?
title_fullStr Genetic markers in breast cancer – how far fave we come from BRCA1?
title_full_unstemmed Genetic markers in breast cancer – how far fave we come from BRCA1?
title_sort genetic markers in breast cancer – how far fave we come from brca1?
publisher UKM Medical Molecular biology Institute, UMBI
publishDate 2011
url http://journalarticle.ukm.my/3061/
http://journalarticle.ukm.my/3061/
http://journalarticle.ukm.my/3061/1/2011-1-3.pdf
first_indexed 2023-09-18T19:37:46Z
last_indexed 2023-09-18T19:37:46Z
_version_ 1777405385680879616